| November 4, 2023 (Saturday) | ||
|---|---|---|
| Room 201, 2F | ||
| 13:30-16:30 | Pre-conference Workshop: Controversies of COVID-19 Vaccines | |
| Moderator: Bruce Mungall (Singapore), Po-Ren Hsueh (Taiwan) | ||
| 13:30-14:10 | Adenovirus-Vectored COVID-19 Vaccine: Effective and Safe? | |
| 13:30-13:50 | Adenovirus-Vectored COVID-19 Vaccine: Pros Bruce Mungall (Singapore) |
|
| 13:50-14:10 | Adenovirus-Vectored COVID-19 Vaccine: Cons Wang-Huei Sheng (Taiwan) |
|
| Room 201, 2F | ||
| 14:10-14:50 | mRNA COVID-19 Vaccine: Effective and Safe? | |
| 14:10-14:30 | mRNA COVID-19 Vaccine: Pros Andrea Carfi (USA) |
|
| 14:30-14:50 | mRNA COVID-19 Vaccine: Cons Chih-Jung Chen (Taiwan) |
|
| Room 201, 2F | ||
| 14:50-15:30 | Inactivated Whole-Cell COVID-19 Vaccine: Effective and Safe? | |
| 14:50-15:10 | Inactivated Whole-Cell COVID-19 Vaccine: Pros Juan Carlos Jaramillo (USA) |
|
| 15:10-15:30 | Inactivated Whole-Cell COVID-19 Vaccine: Cons Kuan-Ying A. Huang (Taiwan) |
|
| Room 201, 2F | ||
| 14:50-15:10 | Protein Subunit COVID-19 Vaccine: Effective and Safe? | |
| 15:30-15:50 | Protein Subunit COVID-19 Vaccine: Pros Robert Walker (USA) |
|
| 15:50-16:10 | Protein Subunit COVID-19 Vaccine: Cons Chien-Chang Lee (Taiwan) |
|
| 16:10-16:25 | Discussion | |
| 16:25-16:30 | Concluding Remarks | |
| Po-Ren Hsueh (Taiwan) | ||
| Room 201, 2F | ||
| 16:30-16:50 | Opening Ceremony | |
| Chair: Tzou-Yien Lin (Taiwan) | ||
| Room 201, 2F | ||
| 16:50-17:30 | Keynote Speech 1 | |
| Moderator(s): Li-Min Huang (Taiwan), Tzou-Yien Lin (Taiwan) Universal Vaccine Development Through Glycoengineering Chi-Huey Wong (Taiwan) |
||
| 17:30-18:10 | Keynote Speech 2 | |
| Moderator(s): Li-Min Huang (Taiwan), Tzou-Yien Lin (Taiwan) Novel Approaches in Immunization Bruce Mungall (Singapore) |
||
| Banquet Hall, 3F | ||
| 18:10-21:30 | Welcome Reception | |
| November 5, 2023 (Sunday) | ||
|---|---|---|
| Room 201, 2F | ||
| 08:00-10:00 | Plenary Session 1 | |
| Moderator(s): Kim Mulholland (Australia), Ping-Ing Lee (Taiwan) | ||
| 08:00-08:40 | Vaccines for Emerging Infectious Disease: Past, Present, and Future Kim Mulholland (Australia) |
|
| 08:40-09:20 | Development and Implementation of Malaria Vaccine Adrian Hill (UK) |
|
| 09:20-10:00 | Influenza Vaccine: A Mystery Inside an Enigma Ping-Ing Lee (Taiwan) |
|
| 10:00-10:20 | Coffee Break | |
| Room 201, 2F | ||
| 10:20-12:20 | Plenary Session 2 | |
| Chair: Eun Hwa Choi (Korea), Yhu-Chering Huang (Taiwan) | ||
| 10:20-11:00 | Effectiveness and Safety of COVID-19 Vaccines: Which One is the Best? Yhu-Chering Huang (Taiwan) |
|
| 11:00-11:40 | Virus-vectored Vaccine and mRNA Vaccine: Unique Immune Responses and Unique Adverse Reactions Ger T. Rijkers (Netherlands) |
|
| 11:40-12:20 | Circadian Rhythm and Immune Response to Vaccination Christoph Scheiermann (Switzerland) |
|
| Room 201, 2F | ||
| 12:20-13:40 | Lunch symposium 1 - The New Era of Prevention for Herpes Zoster (GSK sponsored) | |
| Moderator: Ping-Ing Lee (Taiwan) | ||
| 12:20-13:20 | The New Era of Prevention for Herpes Zoster Tino F. Schwarz (Germany) |
|
| 13:20-13:40 | Q&A | |
| Room 102, 1F | ||
| 12:20-13:40 | Lunch symposium 2-MSD | |
| Banquet Hall, 3F | ||
| 12:20-13:40 | Lunch symposium 3 - Deep Understanding of mRNA Science and Its Infinite Possibilities (Moderna sponsored) | |
| Moderator: Yhu-Chering Huang (Taiwan) | ||
| 12:20-12:25 | Opening Yhu-Chering Huang (Taiwan) |
|
| 12:25-12:50 | Interpreting mRNA: Exploring Its Fundamental Characteristics, Safety, and Significant Role in the Future of Medicine Mi-Hua Tao (Taiwan) |
|
| 12:50-13:15 | The Clinical Journey of mRNA Vaccines: Looking at the Present the Various Possibilities for the Future Chi-Long Chen (Taiwan) |
|
| Room 201, 2F | ||
| 14:00-15:30 | Session 2A: COVID-19 Vaccines (1) | |
| Chair: Akihiko Saitoh (Japan), Yi-Tsung Lin (Taiwan) | ||
| 14:00-14:20 | The Use of COVID-19 Vaccine in Children Akihiko Saitoh (Japan) |
|
| 14:20-14:40 | Effectiveness and Safety of COVID-19 Vaccines: Which One is the Best? Yhu-Chering Huang (Taiwan) |
|
| 14:40-15:00 | Immunogenicity and Effectiveness of BNT and CoronaVac Vaccines in Hong Kong Children Yu-lung Lau (Hong Kong) |
|
| 15:00-15:20 | Monitoring of Adverse Events Following COVID-19 Vaccination Wei-I Huang (Taiwan) |
|
| 15:20-15:30 | 10 minutes Discussion | |
| Room 102, 1F | ||
| 14:00-15:30 | Session 2B: Hepatitis, Measles, Mumps and Rubella Vaccines | |
| Chair: Nobuhiko Okabe (Japan), Po-Yen Chen (Taiwan) | ||
| 14:00-14:25 | Preventive Strategies Against Hepatitis Po-Yen Chen (Taiwan) |
|
| 14:25-14:50 | The Use of Hexavalent Vaccine in Infants Hyunju Lee (Korea) |
|
| 14:50-15:15 | Global Resurgence and Control Strategies of Measles and Rubella Nobuhiko Okabe (Japan) |
|
| 15:15-15:30 | 15 minutes Discussion | |
| 15:30-15:50 | Coffee Break | |
| Room 201, 2F | ||
| 15:50-17:20 | Session 3A: COVID-19 Vaccines (2) | |
| Chair: Ki Wook Yun (Korea), Yee-Chun Chen (Taiwan) | ||
| 15:50-16:15 | Impact of COVID-19 on the Epidemiology of Respiratory Tract Infection: The Immune Debt. Eun Hwa Choi (Korea) |
|
| 16:15-16:40 | COVID-19 Vaccine Implementation in the Children and Adolescent Population and Risk Communication Hyunju Lee (Korea) |
|
| 16:40-17:05 | Do We Need Variants COVID-19 Vaccine: The Role of Conserved Neutralizing Epitope and T-Cell Immunity Robert Walker (USA) |
|
| 17:05-17:20 | 15 minutes Discussion | |
| Room 102, 1F | ||
| 15:50-17:20 | Session 3B: Rotavirus and Norovirus Vaccines | |
| Chair: Tony Nelson (Hong Kong), Chun-Yi Lu (Taiwan) | ||
| 15:50-16:10 | Effectiveness and Safety of Rotavirus Vaccine in the Real World Yhu-Chering Huang (Taiwan) |
|
| 16:10-16:30 | IgA and Rotavirus Correlate of Protection Nabi Kanibir (Switzerland) |
|
| 16:30-16:50 | Implementing Rotavirus Vaccines in National Immunization Programmes Tony Nelson (Hong Kong) |
|
| 16:50-17:10 | Development and Challenge of Norovirus Vaccine Ming Tan (USA) |
|
| 17:10-17:20 | 10 minutes Discussion | |
| Room 201, 2F | ||
| 17:20-18:00 | Evening symposium 1: Are We at Risk? An Update of Neisseria Meningitidis (GSK sponsored) | |
| Moderator: Yhu-Chering Huang (Taiwan) | ||
| 17:20-18:00 | Are we at risk? An Update of Neisseria Meningitidis Po-Yen Chen (Taiwan) |
|
| 18:00-18:20 | Q&A | |
| Room 102, 1F | ||
| 17:20-18:20 | Evening symposium 2: Sanofi | |
| Banquet Hall, 3F | ||
| 17:20-18:20 | Evening symposium 3: Optimizing Influenza Prevention Strategies: From Standard to Innovative Vaccines (CSL Seqirus sponsored) | |
| Moderator: Ping-Ing Lee (Taiwan) | ||
| 17:20-17:25 | Opening Ping-Ing Lee (Taiwan) |
|
| 17:25-17:55 | Enhanced influenza vaccines for the 65 y+ population: adjuvant-MF59 Daniel Furtner (Australia) |
|
| 17:55-18:10 | Cost effectiveness of cell-based quadrivalent influenza vaccine (QIVc) in Taiwanese pediatric population Chih-Jing Chen (Taiwan) |
|
| 18:00-18:20 | Q&A, closing | |
| TBC | ||
| 18:30-21:30 | Presidential Dinner (invited only) | |
| November 6, 2023 (Monday) | ||
|---|---|---|
| Room 201, 2F | ||
| 08:00-09:30 | Session 4A: Human Papillomavirus Vaccine | |
| Chair: Daniel Goh (Singapore), Kao-Pin Hwang (Taiwan) | ||
| 08:00-08:25 | Lessons Learned from HPV Vaccination Program in Japan Akihiko Saitoh (Japan) |
|
| 08:25-08:50 | HPV Vaccination Programme in Singapore: Strategies for a Successful School-Based Programme Daniel Goh (Sigapore) |
|
| 08:50-09:15 | Gender-Neutral Vaccination /Head and Neck Cancer Prevention Elmer Joura (Austria) |
|
| 09:15-09:30 | 15 minutes Discussion | |
| Room 102, 1F | ||
| 08:00-09:30 | Session 4B: Tuberculosis and DTP Combination Vaccine | |
| Chair: Zulkifli Ismail (Malaysia), Hsin Chi (Taiwan) | ||
| 08:00-08:25 | Preventive Strategies Against Pertussis Zulkifli Ismail (Malaysia) |
|
| 08:25-08:50 | Safety and Effectiveness of BCG Vaccine Nan-Chang Chiu (Taiwan) |
|
| 08:50-09:15 | Development and Challenge of Tuberculosis Vaccine Nacho Aguilo () |
|
| 09:15-09:30 | 15 minutes Discussion | |
| Room 101 | ||
| 09:30-09:50 | Coffee Break | |
| Room 201, 2F | ||
| 09:50-11:20 | Session 5A: Varicella and Herpes Zoster Vaccine | |
| Chair: Tino F. Schwarz (Germany), Ren-Bin Tang (Taiwan) | ||
| 09:50-10:15 | Varicella, Herpes Zoster, and Stroke Wei-Hua Chen (Taiwan) |
|
| 10:15-10:40 | Effectiveness and Long-Term Protection of Varicella Vaccine in the Real World. Luan-Yin Chang (Taiwan) |
|
| 10:40-11:05 | Epidemiology of Herpes Zoster and Herpes Zoster Vaccine Tino F. Schwarz (Germany) |
|
| 11:05-11:20 | 15 minutes Discussion | |
| Room 102, 1F | ||
| 09:50-11:20 | Session 5B: Influenza Vaccine | |
| Chair: Daniel Furtner (Austria), Yung-Feng Huang (Taiwan) | ||
| 09:50-10:10 | Influenza, Influenza Vaccine and Cerebrovascular Disease Hsin Chi (Taiwan) |
|
| 10:10-10:30 | New Advance in Influenza Vaccine: Cell-Based Vaccine Daniel Furtner (Austria) |
|
| 10:30-10:50 | Influenza Vaccine for the Elderly Angel Chu (Canada) |
|
| 10:50-11:10 | What's New in Influenza: Updates and Recommendations for 65y+ Hee-Jin Cheong (Korea) |
|
| 11:10-11:20 | 10 minutes Discussion | |
| Room 201, 2F | ||
| 11:20-12:50 | Session 6A: Asian Strategic Alliance for Pneumococcal Disease Prevention Symposium | |
| Chair: Iqbal Ahmad Memon (Pakistan), Wen-Sen Lee (Taiwan) | ||
| 11:20-11:45 | Update on the Implementation of Pneumococcal Conjugate Vaccine in Children in Asia Pacific Region Lulu Bravo (Philippines) |
|
| 11:45-12:05 | Changing Epidemiology of Pneumococcal Infection in the Post-Vaccine Era Cheng-Hsun Chiu (Taiwan) |
|
| 12:10-12:35 | What's New in Influenza: Updates and Recommendations for 65y+ Ger T. Rijkers (Netherlands) |
|
| 12:35-12:50 | 15 minutes Discussion | |
| Room 102, 1F | ||
| 11:20-12:50 | Session 6B: Vaccines for Vector-Borne Viral Diseases and Meningococcal Infection | |
| Chair: Sanath P. Lamabadusuriya (Sri Lanka); Ching-Chuan Liu (Taiwan) | ||
| 11:20-11:40 | An Overview of Japanese Encephalitis Vaccine Rajeshwar Dayal (India) |
|
| 11:40-12:00 | Development of Dengue Vaccine Chiam Sue Yin (Malaysia) |
|
| 12:00-12:20 | Meningococcus Vaccine Po-Yen Chen (Taiwan) |
|
| 12:20-12:40 | Chikungunya and Zika Virus Vaccines Juan Carlos Jaramillo (USA) |
|
| 12:40-12:50 | 10 minutes Discussion | |
| Room 201, 2F | ||
| 12:50-13:50 | Lunch symposium 4: The New Generations of Pneumococcal Vaccines (Pfizer sponsored) | |
| Moderator: Feng-Yee Chang (Taiwan) | ||
| 12:50-12:55 | Opening | |
| 12:55-13:35 | The New Generations of Pneumococcal Vaccines Cheng-Hsun Chiu (Taiwan) |
|
| 13:35-13:45 | Discussion | |
| 13:45-13:50 | Closing | |
| Room 102, 1F | ||
| 12:50-13:50 | Lunch symposium 5: Sanofi | |
| Room 201, 2F | ||
| 13:50-15:20 | Session 7A: Respiratory Syncytial Virus Vaccine | |
| Chair: Christian Feltor (UK), Chun-Yi Lee (Taiwan) | ||
| 13:50-14:10 | Respiratory Syncytial Virus Infection Grant Waterer (Australia) |
|
| 14:10-14:30 | Respiratory Syncytial Virus Vaccine: Epidemiology and Vaccine Development Renato T. Stein (Brazil) |
|
| 14:30-14:50 | Respiratory Syncytial Virus Vaccine Tino F. Schwarz (Germany) |
|
| 14:50-15:10 | Preventive Strategies for Respiratory Syncytial Virus Christian Feltor (UK) |
|
| 15:10-15:20 | 10 minutes Discussion | |
| Room 102, 1F | ||
| 13:50-15:20 | Session 7B: New Vaccine Development | |
| Chair: Patrick Woo (Hong Kong), Po-Ren Hsueh (Taiwan) | ||
| 13:50-14:15 | Development of Pseudovirus Nanoparticle-Based Vaccines Ming Tan (USA) |
|
| 14:15-14:40 | A Candidate Vaccine for Talaromyces Marneffei: Insights for Fungal Vaccine Development Patrick Woo (Hong Kong) |
|
| 14:40-15:05 | Immunology and Development of Enterovirus 71 Vaccine Chun-Yi Lu (Taiwan) |
|
| 15:05-15:20 | 15 minutes Discussion | |
| TBC | ||
| 15:30-21:00 | Local Tour and Dinner (Self-Pay) | |